Absci Corp at Cowen Health Care Conference - Fireside Chat Transcript
Hi. Our next team here in the data-driven antibody discovery space is Absci. It's my pleasure to welcome Sean McClain, Founder and CEO of Absci; Josh Meier, Head of AI; and Greg Schiffman, Chief Financial Officer. (Conference Instructions)
All right. So Sean, maybe you can just give a quick introduction to Absci for those that are unfamiliar with the company.
Yeah, absolutely. So Absci is a generative AI drug-creation company that is really going from this paradigm of drug discovery, where you're finding the needle in the haystack to drug creation, where you're actually being able to create the needle. In our case, the biologic, being able to combine biology along with generative AI to actually start designing antibodies with the specifications you want the first go around, being able to hit the location of the target that you want, the affinity, and have all the developability and manufacturability.
And what this is going to start enabling is us to
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
